| |
|
|
|
|
|
|
|||
|
Blood, Vol. 96 No. 1 (July 1), 2000:
pp. 362-364
BRIEF REPORT
From the Department of Medical Chemistry, Faculty of Medicine, Kyoto
University, Yoshida, Sakyo-ku, and the Center for Molecular Biology and
Genetics, Kyoto University, Shogo-in, Sakyo-ku, Kyoto, Japan.
To isolate soluble factors expressed in early phases of
hematopoietic differentiation, we applied the signal sequence trap method to the in vitro murine hematopoietic differentiation system, in
which ES cells are cocultured with OP-9 stroma cells. This strategy
allowed us to isolate cDNA for a secreted protein, ESOP-1, of 160 amino
acids, the sequence of which shows 64% identity with human
ESOP-1/MD-2. ESOP-1 mRNA was highly expressed in the mouse embryos at
7.5 days after coitus. Expression of the ESOP-1 mRNA and protein was
shown in the embryonic and adult hematopoietic system. In addition, the
ESOP-1 protein was found in the yolk sac-blood islands, the developing
nervous system, and the adult reproductive system. These results
suggest that ESOP-1 may play some roles in the development or
maintenance of hematopoietic, nervous, and reproductive systems.
(Blood. 2000;96:362-364)
To understand the complex molecular mechanisms for
mesoderm induction and early hematopoiesis of mouse embryos,
several attempts were performed, and some genes were
isolated,1-3 from in vitro differentiation systems that
form embryoid bodies and generate hematopoietic cells from embryonic
stem (ES) cells. More recently, the in vitro system to yield
hematopoietic cells was further refined to avoid the formation of
embryoid bodies by coculturing ES cells with the OP9 stromal cell
line4 or by plating ES cells on collagen IV plates with the
enrichment of differentiated cells by cell sorting.5
Such techniques allowed the identification and characterization of the hemangioblasts, the common precursor of both endothelial cells
and hematopoietic cells.6,7 In addition, several membrane receptors and their ligands have been shown to be involved in the
regulation of hematopoietic stem cell differentiation. The best
examples are c-Kit and its ligand stem cell
factor (SCF), Flk-1/vascular endothelial growth factor
(VEGF),8,9 and Tie2/angiopoietin-1.10,11
Because these factors are too limited to explain the complex
regulation of the in vivo hematopoietic pathway(s), it is likely that
there are other soluble factors involved in the early phases of hematopoiesis.
By combining the ES-OP9 hematopoietic differentiation
system4 and the signal sequence trap method,13
we attempted to isolate cDNA for secreted proteins and membrane
proteins expressed when the hematopoietic progenitor cells appear, and
we isolated a candidate cDNA.14 Here we report the
structure and expression of the cDNA-encoded secreted protein, named
ESOP-1 (ES-OP9 coculture clone-1).
Isolation of ESOP-1 cDNA
Anti-mESOP-1 antibody preparation
Whole-mount immunohistochemistry Specimens were fixed with 2% paraformaldehyde. Immunostaining was performed on whole embryos or after they were sliced into 0.5-mm thick sections, and were visualized using 0.025% p-dimethylaminoazobenzene (Dojin, Tokyo, Japan), 0.08% NiCl2.6H2O, and 0.0075% H2O2.
Murine ESOP-1 (mESOP-1) cDNA encodes a protein of 160 residues with
an N-terminal hydrophobic region (16 residues) that was predicted to be
the signal sequence for secretion.15 In fact Western blot
analysis showed that 5% to 10% of the total ESOP-1 produced was
secreted into the culture supernatant of 293T cells transfected by
ESOP-1 cDNA (data not shown). The human ESOP-1 (hESOP-1) cDNA was also
isolated using mESOP-1 cDNA as probe14; hESOP-1 is composed
of 160 residues and is 64% identical to mESOP-1 (Figure
1A). A database search indicated that
hESOP-1 is identical to MD-2.16
We thank Dr S.-I. Nishikawa and Dr H. Yoshida for their kind gift of
the anti-c-Kit and anti-Flk-1 monoclonal antibodies, their teaching on
whole-mount immunohistochemistry, and the helpful discussions. We thank
N. Tomikawa, M. Tanaka and M. Yamaguchi for their assistance in the
experiments and in the preparation of the manuscript.
Submitted November 19, 1999; accepted February 29, 2000.
Supported in part by grants from the Ministry of Education, Science,
and Culture of Japan (Monbusho) and by a fellowship from the Mochida
Memorial Foundation for Medical and Pharmaceutical Research.
Genbank accession numbers for mouse and human ESOP-1 are AF168120 and
AF168121, respectively.
Reprints: Tasuku Honjo, Department of Medical Chemistry,
Faculty of Medicine, Yoshida, Konoe-cho, Sakyo-ku, Kyoto 606-8507, Japan; e-mail: honjo{at}mfour.med.kyoto-u.ac.jp.
The publication costs of this
article were defrayed in part by
page charge payment. Therefore,
and solely to indicate this fact,
this article is hereby marked
"advertisement"
in accordance with 18 U.S.C.
section 1734.
1.
Guimarães MJ, Bazan JF, Zlotnik A, et al.
A new approach to the study of haematopoietic development in the yolk sac and embryoid bodies.
Development.
1995;121:3335-3346[Abstract].
2.
Choi K, Wall C, Hanratty R, Keller G.
Isolation of a gene encoding a novel receptor tyrosine kinase from differentiated embryonic stem cells.
Oncogene.
1994;9:1261-1266[Medline]
[Order article via Infotrieve].
3.
Shen MM, Wang H, Leder P.
A differential display strategy identifies Cryptic, a novel EGF-related gene expressed in the axial and lateral mesoderm during mouse gastrulation.
Development.
1997;124:429-442[Abstract].
4.
Nakano T, Kodama H, Honjo T.
Generation of lymphohematopoietic cells from embryonic stem cells in culture.
Science.
1994;265:1098-1101
5.
Nishikawa S-I, Nishikawa S, Hirashima M, Matsuyoshi N, Kodama H.
Progressive lineage analysis by cell sorting and culture identifies FLK-1+VE-cadherin+cells at a diverging point of endothelial and hematopoietic lineages.
Development.
1998;125:1747-1757[Abstract].
6.
Nishikawa S-I, Nishikawa S, Kawamoto H, et al.
In vitro generation of lymphohematopoietic cells from endothelial cells purified from murine embryos.
Immunity.
1998;8:761-769[Medline]
[Order article via Infotrieve].
7.
Choi K.
Hemangioblast development and regulation.
Biochem Cell Biol.
1998;76:947-956[Medline]
[Order article via Infotrieve].
8.
Shalaby F, Rossant J, Yamaguchi TP, et al.
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice.
Nature.
1995;376:62-66[Medline]
[Order article via Infotrieve].
9.
Carmeliet P, Ferreira V, Breier G, et al.
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele.
Nature.
1996;380:435-439[Medline]
[Order article via Infotrieve].
10.
Sato TN, Tozawa Y, Deutsch U, et al.
Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation.
Nature.
1995;376:70-74[Medline]
[Order article via Infotrieve].
11.
Suri C, Jones PF, Patan S, et al.
Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis.
Cell.
1996;87:1171-1180[Medline]
[Order article via Infotrieve].
12.
Takakura N, Huang XL, Naruse T, et al.
Critical role of the TIE2 endothelial cell receptor in the development of definitive hematopoiesis.
Immunity.
1998;9:677-686[Medline]
[Order article via Infotrieve].
13.
Tashiro K, Nakamura T, Honjo T.
The signal sequence trap method.
Methods Enzymol.
1999;303:479-495[Medline]
[Order article via Infotrieve].
14. Honjo T, Kato K, Tada H. Isolation of a new polypeptide and cDNA
differentiated ES cells by SST method. International publication number
WO 99/18205. April 15, 1999.
15.
von Heijne.
A new method for predicting signal sequence cleavage sites.
Nucl Acid Res.
1986;14:4683-4690
16.
Shimazu R, Akashi S, Ogata H, et al.
MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4.
J Exp Med.
1999;189:1777-1782
17.
Yoshida H, Takakura N, Hirashima M, et al.
Hematopoietic tissues, as a playground of receptor tyrosine kinases of the PDGF-receptor family.
Dev Comp Immunol.
1998;22:321-332[Medline]
[Order article via Infotrieve].
18.
Orr-Urtreger A, Avivi A, Zimmer Y, Givol D, Yarden Y, Lonai P.
Developmental expression of c-kit, a proto-oncogene encoded by the W locus.
Development.
1990;109:911-923
19.
Hirata T, Morii E, Morimoto M, et al.
Stem cell factor induces outgrowth of c-kit-positive neurites and supports the survival of c-kit-positive neurons in dorsal root ganglia of mouse embryos.
Development.
1993;119:49-56[Abstract].
20.
Yoshida H, Takakura N, Kataoka H, Kunisada T, Okamura H, Nishikawa SI.
Stepwise requirement of c-kit tyrosine kinase in mouse ovarian follicle development.
Dev Biol.
1997;184:122-137[Medline]
[Order article via Infotrieve].
21.
Vincent S, Segretain D, Nishikawa S, et al.
Stage-specific expression of the Kit receptor and its ligand (KL) during male gametogenesis in the mouse: a Kit-KL interaction critical for meiosis.
Development.
1998;125:4585-4593[Abstract].
22.
Hashimoto C, Hadson KL, Anderson KV.
The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein.
Cell.
1988;52:269-679[Medline]
[Order article via Infotrieve].
23.
Halfon MS, Hashimoto C, Keshishian H.
The Drosophila Toll gene functions zygotically and is necessary for proper motoneuron and muscle development.
Dev Biol.
1995;169:151-167[Medline]
[Order article via Infotrieve].
24.
Qui P, Pan PC, Govind S.
A role for the Drosophila Toll/Cactus pathway in larval hematopoiesis.
Development.
1998;125:1909-1920[Abstract].
25.
Hoshino K, Takeuchi O, Kawai T, et al.
Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product.
J Immunol.
1999;162:3749-3752
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2000 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||